阿特拉提利诺利德-I通过抑制炎症来防止腹腔大动脉动脉瘤的形成
Shuxiao Chen1, Xiaotian Liu2, Xincheng Zhou1
1Department of Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Frontiers in immunology
|February 17, 2025
概括
阿特拉提利诺利德-I (ATL-I) 通过抑制血管炎症和巨细胞透,有效地减少腹腔大动脉动脉瘤 (AAA) 的进展. 这种天然化合物向AMPK信号,为AAA疾病提供了潜在的新疗法.
科学领域:
- 血管生物学 血管生物学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 腹腔大动脉动脉瘤 (AAA) 是一种具有高死亡率的退行性血管疾病.
- 慢性炎症是AAA发病的一个关键因素.
- 阿特拉提利诺化物-I (ATL-I) 是一种来自Rhizoma Atractylodis Macrocephalae的化合物,具有抗炎性质.
研究的目的:
- 调查ATL-I在腹腔大动脉瘤 (AAA) 进展中的治疗作用.
主要方法:
- 在小鼠中使用猪胰腺弹性酶 (PPE) 诱导AAA.
- 在诱导后,ATL-I是口服的.
- 评估了血管直径,病理变化和分子标记物 (细胞因子,MMP,-AMPK).
主要成果:
- ATL-I治疗减少了大动脉扩张和AAA发生率.
- ATL-I降低了巨细胞透和促炎细胞因子 (IL-1β,IL-6),同时增加了IL-10.
- ATL-I抑制了MMP-2/9表达,保护了光滑肌肉细胞和弹性纤维,并抑制了高-AMPK信号传递.
结论:
- ATL-I通过向AMPK信号通路来改善血管炎症并抑制AAA的形成.
- ATL-I证明了作为腹腔大动脉动脉瘤的替代治疗剂的潜力.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
457
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
457
Antihypertensive Drugs: Angiotensin II Receptor Blockers
573
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
573
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
Antihypertensive Drugs: Vasodilators
462
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
462
Antihypertensive Drugs: Direct Renin Inhibitors
474
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
474


